ORIGINAL CONTRIBUTIONS |
Lung Function and Glucose Metabolism: An Analysis of Data from the Third National Health and Nutrition Examination Survey
1 Division of Respiratory Medicine, City Hospital, Nottingham, United Kingdom
2 Department of Diabetes, Royal Liverpool University Hospital, Liverpool, United Kingdom
Correspondence to Dr. Tricia McKeever, Division of Respiratory Medicine, Clinical Science Building, City Hospital, Hucknall Road, Nottingham NG5 1PB, United Kingdom (e-mail: Tricia.McKeever{at}Nottingham.ac.uk).
Although people with diabetes have decreased lung function, the dose-response relation between measures of glucose control and lung function in nondiabetic people is not known. The authors used data from the Third National Health and Nutrition Examination Survey (1988–1994) to investigate the relation between glucose tolerance test response and other measures of glucose homeostasis and lung function in an adult population without a clinical diagnosis of diabetes. Plasma glucose level 2 hours after oral administration of 75 g of glucose was inversely related to forced expiratory volume in 1 second (FEV1), with a difference of –144.7 ml (95% confidence interval: –231.9, –57.4) for persons in the highest quintile of postchallenge glucose compared with the lowest. Similar inverse associations with FEV1 were found for other measures of glucose autoregulation. Lung function did not appear to be related to fasting glucose level. Similar associations were seen for forced vital capacity (FVC) but not for the FEV1:FVC ratio. In the total study population, persons with previously diagnosed diabetes had an FEV1 119.1 ml (95% confidence interval: –161.5, –76.6) lower than persons without diabetes. This effect was greater in those with poorly controlled diabetes. These findings suggest that impaired glucose autoregulation is associated with impaired lung function.
glucose; hemoglobin A, glycosylated; insulin; lung; respiratory function tests
Abbreviations: CI confidence interval; FEV1 forced expiratory volume in 1 second; FVC forced vital capacity; NHANES III Third National Health and Nutrition Examination Survey
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. F. Ehrlich, C. P. Quesenberry Jr., S. K. Van Den Eeden, J. Shan, and A. Ferrara Patients Diagnosed With Diabetes Are at Increased Risk for Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, and Pneumonia but Not Lung Cancer Diabetes Care, January 1, 2010; 33(1): 55 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. E. K. Pogson, T. M. McKeever, and A. Fogarty The association between serum osmolality and lung function among adults Eur. Respir. J., July 1, 2008; 32(1): 98 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Lauruschkat, B. Arnrich, A. A. Albert, J. A. Walter, B. Amann, U. P. Rosendahl, T. Alexander, and J. Ennker Diabetes mellitus as a risk factor for pulmonary complications after coronary bypass surgery. J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 1047 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Innes and H. K. Vincent The Influence of Yoga-Based Programs on Risk Profiles in Adults with Type 2 Diabetes Mellitus: A Systematic Review Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 469 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W Fogarty, S. Jones, J. R Britton, S. A Lewis, and T. M McKeever Systemic inflammation and decline in lung function in a general population: a prospective study Thorax, June 1, 2007; 62(6): 515 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M.E. Davis and W. A. Davis An Assessment of Eligibility for Inhaled Insulin (Exubera): The Fremantle Diabetes Study Diabetes Care, February 1, 2007; 30(2): 360 - 361. [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Teeter and R. J. Riese Dissociation of Lung Function Changes with Humoral Immunity during Inhaled Human Insulin Therapy Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1194 - 1200. [Abstract] [Full Text] [PDF]
|
|